Certainly investing in BIAD vs ZENO has greater upside potential. Plus BIAD is pursuing more than just MIDS. COAG has massive potential too with a new partner. Recall what happened when Sysmex made a small commitment to BIAD? We were at $.22-.23/ share in a hurry from $.03 and still considered undervalued.
Please keep the open line of communication with Tom Barr. Much appreciated.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.